var data={"title":"Infantile hemangiomas: Evaluation and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Infantile hemangiomas: Evaluation and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Denise W Metry, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 06, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infantile hemangiomas are benign tumors of vascular endothelium and the most common tumors of childhood [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Despite their benign and self-limited nature, some hemangiomas can cause complications such as ulceration or life-altering disfigurement. Occasionally, hemangiomas may compromise vital organ function or may occur in association with developmental anomalies.</p><p>The evaluation of infantile hemangiomas will be discussed here. The epidemiology, pathogenesis, clinical features, complications, and management are discussed separately. (See <a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications&quot;</a> and <a href=\"topic.htm?path=infantile-hemangiomas-management\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">DIAGNOSIS AND EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the vast majority of cases the diagnosis of a hemangioma can be established clinically, based upon the history and physical examination [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. However, deeper subcutaneous lesions without the characteristic overlying skin changes and hepatic lesions (especially in the absence of a cutaneous hemangioma) may be very difficult to distinguish from vascular malformations or other tumors. Although imaging studies can be helpful [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/3-6\" class=\"abstract_t\">3-6</a>], tissue biopsy is generally needed for definitive diagnosis in concerning cases.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">History</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Important aspects of the history for a child with a vascular lesion include [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Age at which the lesion was first noted and subsequent behavior of the lesion.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Presence of ulceration, pain, bleeding <span class=\"nowrap\">and/or</span> evidence of secondary infection.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Whether any imaging studies, biopsies, or other prior evaluations (including subspecialty) have been performed.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Previous treatment and response.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Progressive respiratory difficulty in the first several months of life, particularly if a hemangioma is in a cervicofacial or mandibular (&quot;beard&quot;) distribution (<a href=\"image.htm?imageKey=PEDS%2F58168\" class=\"graphic graphic_picture graphicRef58168 \">picture 1</a>) (may indicate the simultaneous presence of airway hemangioma).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Signs of high-output cardiac failure during early infancy in the presence of multiple (five or more) cutaneous hemangiomas (may indicate the presence of hepatic hemangiomas).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapid growth, along with tenseness, purpuric appearance, or widespread telangiectasias in the presence of a very low platelet count (may indicate the Kasabach-Merritt phenomenon in the case of a kaposiform hemangioendothelioma or tufted angioma &ndash; vascular tumors distinct from infantile hemangiomas). (See <a href=\"topic.htm?path=tufted-angioma-kaposiform-hemangioendothelioma-and-the-kasabach-merritt-phenomenon\" class=\"medical medical_review\">&quot;Tufted angioma, kaposiform hemangioendothelioma, and the Kasabach-Merritt phenomenon&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Any parental preconceptions: What have they already learned about the potential diagnosis and treatment options? What concerns them the most about their child's lesion(s)?</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The physical examination should include [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Careful examination of the skin and mucous membranes</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Documentation of lesion morphology and location, and approximate size</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Documentation of the presence and severity of ulceration, and whether there is clinical evidence of secondary infection</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Palpation of the liver for hepatomegaly and evaluation for abdominal bruit if clinically indicated, including evaluation for signs of high-output heart failure (eg, tachycardia, wide pulse pressure, bounding pulses, midsystolic murmur, <span class=\"nowrap\">and/or</span> a third heart sound caused by the increased rate of ventricular filling)</p><p/><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Additional studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most hemangiomas can be diagnosed clinically without additional studies. In the minority of cases where the diagnosis is in question, imaging (ultrasonography, computed tomography [CT], or magnetic resonance (MR) imaging) can be helpful, but should not be relied upon if there is any question of malignancy, in which case tissue biopsy is generally necessary. Imaging may also be useful in evaluating the extent of a complicated hemangioma, evaluating for other potential anomalies when clinically indicated (eg, PHACE syndrome), or following response to therapy, particularly in the case of hepatic hemangiomas. (See <a href=\"#H6\" class=\"local\">'Additional evaluation'</a> below and <a href=\"#H14\" class=\"local\">'Differential diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">ADDITIONAL EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Depending upon the location and morphology of the hemangioma, additional evaluation <span class=\"nowrap\">and/or</span> referral may be necessary.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Periorbital hemangiomas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Periorbital hemangiomas may compromise normal visual development (<a href=\"image.htm?imageKey=DERM%2F50631\" class=\"graphic graphic_picture graphicRef50631 \">picture 2</a>). In concerning cases, early examination by an ophthalmologist familiar with the evaluation and treatment of periorbital hemangiomas is mandatory [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>]. Patients with large, segmental hemangiomas, may also be at risk for PHACE syndrome. (See <a href=\"#H8\" class=\"local\">'Segmental hemangiomas'</a> below and <a href=\"#H13165020\" class=\"local\">'PHACE syndrome'</a> below.) </p><p>The management of periorbital hemangiomas is discussed separately. (See <a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications#H15\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications&quot;, section on 'Complications'</a> and <a href=\"topic.htm?path=infantile-hemangiomas-management\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Segmental hemangiomas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Segmental hemangiomas are usually plaque-like and demonstrate linear <span class=\"nowrap\">and/or</span> geographic patterning (<a href=\"image.htm?imageKey=PEDS%2F82212\" class=\"graphic graphic_picture graphicRef82212 \">picture 3</a>) [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/9\" class=\"abstract_t\">9</a>]. Similar to multiple (&ge;5) cutaneous hemangiomas, segmental hemangiomas may also be associated with visceral hemangiomatosis [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/10,11\" class=\"abstract_t\">10,11</a>]. The locations of visceral lesions often correlate regionally with the sites of cutaneous lesions. Visceral hemangiomas undergo spontaneous involution as do their cutaneous counterparts, probably most often without sequelae. For this reason, evaluation of infants with segmental hemangiomas depends upon the anatomic location and, most importantly, the presence of clinical signs and symptoms as discussed below [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>]. Imaging of asymptomatic<strong> </strong>infants with segmental hemangiomas for visceral hemangiomatosis is <strong>not</strong> recommended because of the expense and usual need for general anesthesia in young infants. </p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Beard distribution</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infants with segmental cervicofacial or mandibular hemangiomas in a &quot;beard&quot; distribution (<a href=\"image.htm?imageKey=PEDS%2F58168\" class=\"graphic graphic_picture graphicRef58168 \">picture 1</a>) should be clinically monitored for signs of airway involvement (eg, progressive hoarseness, stridor) [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/12\" class=\"abstract_t\">12</a>]. The possibility of PHACE syndrome should also be considered in these patients. (See <a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications#H15\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications&quot;, section on 'Complications'</a>.)</p><p class=\"headingAnchor\" id=\"H13165020\"><span class=\"h3\">PHACE syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infants with large (&gt;5 cm in diameter), segmental hemangiomas, particularly when located on the face, scalp, or posterior <span class=\"nowrap\">head/neck,</span> are at risk for PHACE syndrome (<a href=\"image.htm?imageKey=PEDS%2F80245\" class=\"graphic graphic_table graphicRef80245 \">table 1</a> and <a href=\"image.htm?imageKey=DERM%2F70599\" class=\"graphic graphic_picture graphicRef70599 \">picture 4</a>) [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/13-16\" class=\"abstract_t\">13-16</a>]. The clinical features of PHACE syndrome are discussed separately. (See <a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications#H6\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications&quot;, section on 'Clinical features'</a>.)</p><p>Infants at risk for PHACE syndrome should undergo careful cutaneous, ophthalmologic, cardiac, and neurologic evaluations [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/16,17\" class=\"abstract_t\">16,17</a>]. An echocardiogram is mandatory prior to the initiation of <a href=\"topic.htm?path=propranolol-drug-information\" class=\"drug drug_general\">propranolol</a> to rule-out the possibility of severe aortic coarctation, a contraindication to propranolol use. Magnetic resonance (MR) imaging with angiography of the head and neck is also indicated, given the potential for neurologic sequelae in the presence of structural or vascular anomalies. [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/18-20\" class=\"abstract_t\">18-20</a>]. Head and neck imaging is also preferred prior to propranolol initiation, unless the clinical situation requires urgent treatment (eg, severe visual obstruction due to an orbital hemangioma). Infants should be evaluated by an ophthalmologist. (See <a href=\"topic.htm?path=infantile-hemangiomas-management#H295343597\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Management&quot;, section on 'PHACE syndrome'</a>.)</p><p>Hearing loss (conductive or sensorineural) has been reported in patients with PHACE syndrome, particularly in those with hemangiomas involving the scalp, including the ear and periauricular skin [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]. This can be related to the presence of ipsilateral intracranial hemangiomas involving auditory structures. Children with PHACE and hemangiomas in the periauricular area should be evaluated with both MR imaging and repeat audiometric testing during infancy, in addition to the newborn screening [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Lumbosacral</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Segmental hemangiomas over the midline lumbosacral spine (<a href=\"image.htm?imageKey=PEDS%2F72298\" class=\"graphic graphic_picture graphicRef72298 \">picture 5</a>) may be associated with spinal dysraphism <span class=\"nowrap\">and/or</span> anal or genitourinary anomalies, including tethered spinal cord, lipomyelomeningocele, bony anomalies of the sacrum, abnormal genitalia, imperforate anus with fistula formation, or renal abnormalities [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/22-30\" class=\"abstract_t\">22-30</a>]. MR imaging is the most sensitive means of definitive diagnosis of spinal anomalies and should be performed in all infants or older children with a segmental hemangioma over the lumbosacral spine.</p><p>Screening of patients with midline hemangiomas in the lumbosacral area is supported by the results of a multicenter, prospective cohort study [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]. In this study, MR imaging detected spinal anomalies in 21 out of 41 children (51 percent) with localized or segmental lumbosacral hemangiomas that were greater than or equal to 2.5 cm in size (risk ratio 640, 95% CI 404-954). The study did not evaluate imaging in patients with smaller lesions, and it is unclear whether these results translate to patients with small, localized hemangiomas. A retrospective study evaluated the types of spinal dysraphism in children with lumbosacral hemangioma [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/28\" class=\"abstract_t\">28</a>]. Among 20 children with lumbosacral hemangioma and spinal dysraphism, 12 had tethered cord, 10 spinal lipoma or lipomyelomeningocele, 9 intraspinal hemangiomas, and 8 sinus tract [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/28\" class=\"abstract_t\">28</a>].</p><p>Unlike MR imaging, ultrasonographic examination does not require sedation in infants. Some authors have suggested that ultrasonography can be performed instead of MR imaging in infants younger than four months of age if expertise in pediatric ultrasonography is available [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/23,24,26\" class=\"abstract_t\">23,24,26</a>]. However, ultrasounds may miss some spinal abnormalities. In the cohort study described above, 5 out of 12 patients (42 percent) with normal ultrasound examinations subsequently were noted to have spinal anomalies on MR imaging [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>]. The average age of patients who received ultrasounds in the study was two months. The sensitivity and specificity of ultrasonography were 50 (95% CI 19-81) and 78 (95% CI 40-97) percent, respectively. Another prospective study also found that ultrasounds failed to detect spinal dysraphism in some patients; the diagnosis was missed in 15 percent of infants under the age of six months who had hemangiomas or lipomas overlying the involved area [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>].</p><p>Thus, MR imaging remains the gold standard for evaluating patients with lumbosacral hemangiomas for underlying spinal disorders. In young infants, ultrasonography can be used as an initial test and MR imaging can be delayed until the age of four to six months if there are no clinical findings that indicate the need for earlier evaluation (patent sinus tracts, ulceration, or neurologic signs or symptoms) [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/31\" class=\"abstract_t\">31</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Multiple hemangiomas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately 30 percent of infants have more than one hemangioma, but only 3 percent have six or more lesions [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>]. Multifocal cutaneous hemangiomas at-risk for concomitant visceral hemangiomas (ie, diffuse neonatal hemangiomatosis [DNH]) are defined as &ge;5 small, localized lesions. The liver is the extracutaneous site most frequently involved, whereas involvement of other sites, such as the gastrointestinal tract or the brain, is rare. In most cases, hepatic hemangiomas are asymptomatic and only rarely cause major complications. </p><p>Infants with two or three cutaneous hemangiomas do not require further visceral evaluation or monitoring if findings on physical examination are normal (with the exception of the cutaneous hemangiomas) [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/34\" class=\"abstract_t\">34</a>]. In contrast, it is generally recommended that infants younger than six months with &ge;5 cutaneous hemangiomas undergo early evaluation with abdominal ultrasound and be monitored clinically [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/35,36\" class=\"abstract_t\">35,36</a>]. This recommendation is supported by a prospective study, in which 16 percent of infants with &ge;5 hemangiomas had solitary or multiple hepatic hemangiomas and 1.3 percent had airway or gastrointestinal hemangiomas [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. None of the children with &le;4 cutaneous hemangiomas had visceral lesions. Only one child with hepatic hemangioma was symptomatic with hepatomegaly and high-output congestive heart failure and required treatment with <a href=\"topic.htm?path=propranolol-drug-information\" class=\"drug drug_general\">propranolol</a> and oral corticosteroids. Infants with hepatic hemangiomas should also be screened for hypothyroidism [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/38\" class=\"abstract_t\">38</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Large hemangiomas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An increased risk for hepatic hemangiomas in infants with large hemangiomas has been suggested in two small retrospective studies [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/11,39\" class=\"abstract_t\">11,39</a>]. In contrast, a prospective study found no hepatic hemangiomas in 60 infants with at least one hemangioma &gt;30 cm<sup>2</sup> [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>]. Infants with large hemangiomas do not need to be routinely screened for hepatic hemangiomas with ultrasonography purely based upon lesion size. However, if signs or symptoms that suggest hepatic hemangiomas (poor growth or feeding, tachypnea, cardiac murmur, abdominal distension, or hepatomegaly) are present, evaluation is indicated [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As mentioned above, the diagnosis of infantile hemangiomas can be made on the basis of history and physical examination in the vast majority of cases. Cases in which the diagnosis may be difficult include [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/41\" class=\"abstract_t\">41</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In about one-third of cases, infantile hemangioma is present at birth as a macular telangiectatic patch (<a href=\"image.htm?imageKey=DERM%2F89391\" class=\"graphic graphic_picture graphicRef89391 \">picture 6</a>) similar in appearance to a capillary malformation (ie, port-wine stain) [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>]. Hemangiomas with this presentation often have surrounding pallor representing vasoconstriction, which can help to differentiate them from capillary malformations early on. In addition, in contrast with capillary malformations, hemangiomas quickly begin to develop small vascular blebs and become raised (<a href=\"image.htm?imageKey=DERM%2F65721\" class=\"graphic graphic_picture graphicRef65721 \">picture 7</a>). Early arteriovenous malformations of the skin can also present as a cutaneous &quot;blush&quot; that is sometimes initially misdiagnosed as an infantile hemangioma. (See <a href=\"topic.htm?path=capillary-malformations-port-wine-stains-and-associated-syndromes\" class=\"medical medical_review\">&quot;Capillary malformations (port wine stains) and associated syndromes&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Large vascular lesions that are congenital (ie, &quot;fully developed&quot; at birth) are very unlikely to be true infantile hemangiomas, which are characterized by proliferation <strong>after</strong> birth. The differential diagnosis includes vascular malformations, rapidly involuting or noninvoluting congenital &quot;hemangiomas&quot; (<a href=\"image.htm?imageKey=DERM%2F88803%7EDERM%2F88907\" class=\"graphic graphic_picture graphicRef88803 graphicRef88907 \">picture 8A-B</a>), or other benign and malignant vascular tumors, diagnoses that can often be made clinically by a specialist familiar with such entities [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/22,42,43\" class=\"abstract_t\">22,42,43</a>]. (See <a href=\"topic.htm?path=venous-malformations\" class=\"medical medical_review\">&quot;Venous malformations&quot;</a> and <a href=\"topic.htm?path=rapidly-involuting-congenital-hemangioma-rich-and-noninvoluting-congenital-hemangioma-nich\" class=\"medical medical_review\">&quot;Rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapidly proliferating, violaceous tumors in the setting of the Kasabach-Merritt phenomenon are not infantile hemangiomas but one of two other histologically benign but sometimes aggressive vascular tumors: kaposiform hemangioendothelioma (most commonly) (<a href=\"image.htm?imageKey=DERM%2F89343\" class=\"graphic graphic_picture graphicRef89343 \">picture 9</a>) or tufted angioma (<a href=\"image.htm?imageKey=DERM%2F89065\" class=\"graphic graphic_picture graphicRef89065 \">picture 10</a>). (See <a href=\"topic.htm?path=tufted-angioma-kaposiform-hemangioendothelioma-and-the-kasabach-merritt-phenomenon\" class=\"medical medical_review\">&quot;Tufted angioma, kaposiform hemangioendothelioma, and the Kasabach-Merritt phenomenon&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Deep, subcutaneous tumors, particularly when no overlying skin changes are present to assist with diagnosis, should be suspect, as should any vascular lesion with an atypical clinical appearance or unusual behavior. Although imaging may be helpful, tissue biopsy is generally necessary in concerning cases in order to exclude malignancy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatic hemangiomas may be very difficult to distinguish from vascular (particularly arterio-venous) malformations or other tumors, especially in infants without cutaneous hemangiomas. Radiologic imaging may help in making this distinction [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/34\" class=\"abstract_t\">34</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pyogenic granuloma (<a href=\"image.htm?imageKey=DERM%2F67395\" class=\"graphic graphic_picture graphicRef67395 \">picture 11</a>) is an acquired lesion that is generally small (often less than 1 cm) and develops on the face or upper trunk in a preschool or school-aged child. Lesions are often friable and complicated by recurrent bleeding [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/44\" class=\"abstract_t\">44</a>]. (See <a href=\"topic.htm?path=pyogenic-granuloma-lobular-capillary-hemangioma\" class=\"medical medical_review\">&quot;Pyogenic granuloma (Lobular capillary hemangioma)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other lesions that can occasionally mimic infantile hemangiomas include plexiform neurofibroma, infantile fibrosarcoma, dermatofibrosarcoma protuberans, rhabdomyosarcoma, nasal glioma, dermoid cysts, and infantile myofibroma [<a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/7,41,45\" class=\"abstract_t\">7,41,45</a>]. These lesions generally have a distinct clinical and histologic appearance. (See <a href=\"topic.htm?path=skin-nodules-in-newborns-and-infants\" class=\"medical medical_review\">&quot;Skin nodules in newborns and infants&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Referral to an appropriate and experienced specialist is indicated for the following infants and children: those in whom the diagnosis is in question, those who have actual or potential organ complications, particularly when the lesion is segmental. Early referral, ideally within the first three months of life, is also indicated for infants for whom systemic therapy is being considered. (See <a href=\"#H6\" class=\"local\">'Additional evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants with periorbital hemangiomas at-risk for visual compromise (<a href=\"image.htm?imageKey=PEDS%2F82212\" class=\"graphic graphic_picture graphicRef82212 \">picture 3</a>) should be referred to an ophthalmologist familiar with the evaluation and treatment of periorbital hemangiomas. Patients with segmental facial hemangiomas involving the periorbital skin may also be at risk for PHACE syndrome. (See <a href=\"#H7\" class=\"local\">'Periorbital hemangiomas'</a> above and <a href=\"#H13165020\" class=\"local\">'PHACE syndrome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants with segmental hemangiomas, particularly when located on the face (<a href=\"image.htm?imageKey=PEDS%2F58168\" class=\"graphic graphic_picture graphicRef58168 \">picture 1</a>) should be monitored carefully during infancy for signs of respiratory distress and should be evaluated for PHACE syndrome. (See <a href=\"#H9\" class=\"local\">'Beard distribution'</a> above and <a href=\"#H13165020\" class=\"local\">'PHACE syndrome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants and children with segmental hemangiomas overlying the midline lumbosacral spine (<a href=\"image.htm?imageKey=PEDS%2F72298\" class=\"graphic graphic_picture graphicRef72298 \">picture 5</a>) should be evaluated for spinal dysraphism with magnetic resonance (MR) imaging. (See <a href=\"#H11\" class=\"local\">'Lumbosacral'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants with large (&gt;5 cm in diameter), segmental hemangiomas, particularly when located on the face, scalp or posterior neck (<a href=\"image.htm?imageKey=DERM%2F70599\" class=\"graphic graphic_picture graphicRef70599 \">picture 4</a>), are at risk for PHACE syndrome (<a href=\"image.htm?imageKey=PEDS%2F80245\" class=\"graphic graphic_table graphicRef80245 \">table 1</a>) and should undergo careful cutaneous, ophthalmologic, cardiac, and neurologic evaluations. An echocardiogram is mandatory prior to the initiation of <a href=\"topic.htm?path=propranolol-drug-information\" class=\"drug drug_general\">propranolol</a> to rule-out the possibility of severe aortic coarctation, a contraindication to propranolol use. MR imaging with angiography of the head and neck is also indicated, and should also preferably be performed prior to propranolol initiation. (See <a href=\"#H13165020\" class=\"local\">'PHACE syndrome'</a> above and <a href=\"topic.htm?path=infantile-hemangiomas-management#H295343597\" class=\"medical medical_review\">&quot;Infantile hemangiomas: Management&quot;, section on 'PHACE syndrome'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infants younger than six months with &ge;5 small cutaneous hemangiomas should undergo ultrasonography of the abdomen for potential liver hemangiomas and be monitored clinically. (See <a href=\"#H12\" class=\"local\">'Multiple hemangiomas'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">L&eacute;aut&eacute;-Labr&egrave;ze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390:85.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983; 18:894.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993; 10:311.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998; 16:455.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Dubois J, Garel L, Grignon A, et al. Imaging of hemangiomas and vascular malformations in children. Acad Radiol 1998; 5:390.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Paltiel HJ, Burrows PE, Kozakewich HP, et al. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 2000; 214:747.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Frieden IJ, Eichenfield LF, Esterly NB, et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997; 37:631.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 1996; 26:3.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117:698.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002; 138:1567.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Metry DW, Hawrot A, Altman C, Frieden IJ. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 2004; 140:591.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a &quot;beard&quot; distribution. J Pediatr 1997; 131:643.</a></li><li class=\"breakAll\">PHACE Association. Online Mendelian Inheritance in Man (OMIM) website. OMIM entry #606519. www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM (Accessed on January 18, 2006).</li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Metry DW, Dowd CF, Barkovich AJ, Frieden IJ. The many faces of PHACE syndrome. J Pediatr 2001; 139:117.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126:e418.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Metry D, Heyer G, Hess C, et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 2009; 124:1447.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Metry DW, Garzon MC, Drolet BA, et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009; 26:381.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Bhattacharya JJ, Luo CB, Alvarez H, et al. PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions. Neuroradiology 2004; 46:227.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Burrows PE, Robertson RL, Mulliken JB, et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998; 207:601.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Drolet BA, Dohil M, Golomb MR, et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006; 117:959.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Duffy KJ, Runge-Samuelson C, Bayer ML, et al. Association of hearing loss with PHACE syndrome. Arch Dermatol 2010; 146:1391.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48:477.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 1986; 122:684.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">McAtee-Smith J, Hebert AA, Rapini RP, Goldberg NS. Skin lesions of the spinal axis and spinal dysraphism. Fifteen cases and a review of the literature. Arch Pediatr Adolesc Med 1994; 148:740.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989; 83:977.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Tubbs RS, Wellons JC 3rd, Iskandar BJ, Oakes WJ. Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism. J Neurosurg 2004; 100:86.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Girard C, Bigorre M, Guillot B, Bessis D. PELVIS Syndrome. Arch Dermatol 2006; 142:884.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Schumacher WE, Drolet BA, Maheshwari M, et al. Spinal dysraphism associated with the cutaneous lumbosacral infantile hemangioma: a neuroradiological review. Pediatr Radiol 2012; 42:315.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 2010; 157:795.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Stockman A, Boralevi F, Ta&iuml;eb A, L&eacute;aut&eacute;-Labr&egrave;ze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology 2007; 214:40.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Drolet BA, Chamlin SL, Garzon MC, et al. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr 2010; 157:789.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Sardana K, Gupta R, Garg VK, et al. A prospective study of cutaneous manifestations of spinal dysraphism from India. Pediatr Dermatol 2009; 26:688.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129:346.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Dickie B, Dasgupta R, Nair R, et al. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009; 44:125.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Kulungowski AM, Alomari AI, Chawla A, et al. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 2012; 47:165.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Horii KA, Drolet BA, Frieden IJ, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol 2011; 28:245.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343:185.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Hughes JA, Hill V, Patel K, et al. Cutaneous haemangioma: prevalence and sonographic characteristics of associated hepatic haemangioma. Clin Radiol 2004; 59:273.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Horii KA, Drolet BA, Baselga E, et al. Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol 2010; 146:201.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Garzon MC, Frieden IJ. Hemangiomas: when to worry. Pediatr Ann 2000; 29:58.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Enjolras O, Mulliken JB, Boon LM, et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107:1647.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Pediatr Dermatol 2002; 19:5.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Frieden IJ, Esterly NB. Pyogenic granulomas of infancy masquerading as strawberry hemangiomas. Pediatrics 1992; 90:989.</a></li><li><a href=\"https://www.uptodate.com/contents/infantile-hemangiomas-evaluation-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Brockman RM, Humphrey SR, Moe DC, et al. Mimickers of Infantile Hemangiomas. Pediatr Dermatol 2017; 34:331.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5793 Version 20.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">DIAGNOSIS AND EVALUATION</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">History</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Examination</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Additional studies</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">ADDITIONAL EVALUATION</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">Periorbital hemangiomas</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Segmental hemangiomas</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">- Beard distribution</a></li><li><a href=\"#H13165020\" id=\"outline-link-H13165020\">- PHACE syndrome</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Lumbosacral</a></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">Multiple hemangiomas</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Large hemangiomas</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/5793|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/58168\" class=\"graphic graphic_picture\">- Beard distribution hemangioma</a></li><li><a href=\"image.htm?imageKey=DERM/50631\" class=\"graphic graphic_picture\">- Periocular hemangioma</a></li><li><a href=\"image.htm?imageKey=PEDS/82212\" class=\"graphic graphic_picture\">- Segmental hemangioma</a></li><li><a href=\"image.htm?imageKey=DERM/70599\" class=\"graphic graphic_picture\">- PHACE syndrome 1</a></li><li><a href=\"image.htm?imageKey=PEDS/72298\" class=\"graphic graphic_picture\">- Lumbosacral hemangioma</a></li><li><a href=\"image.htm?imageKey=DERM/89391\" class=\"graphic graphic_picture\">- Infantile hemangioma precursor</a></li><li><a href=\"image.htm?imageKey=DERM/65721\" class=\"graphic graphic_picture\">- Infantile hemangioma - arrested growth</a></li><li><a href=\"image.htm?imageKey=DERM/88803\" class=\"graphic graphic_picture\">- Rapidly involuting congenital hemangioma 2</a></li><li><a href=\"image.htm?imageKey=DERM/88907\" class=\"graphic graphic_picture\">- Noninvoluting congenital hemangioma 1</a></li><li><a href=\"image.htm?imageKey=DERM/89343\" class=\"graphic graphic_picture\">- Kaposiform hemangioendothelioma 2</a></li><li><a href=\"image.htm?imageKey=DERM/89065\" class=\"graphic graphic_picture\">- Tufted angioma</a></li><li><a href=\"image.htm?imageKey=DERM/67395\" class=\"graphic graphic_picture\">- Pyogenic granuloma - chest</a></li></ul></li><li><div id=\"DERM/5793|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/80245\" class=\"graphic graphic_table\">- PHACE syndrome</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=capillary-malformations-port-wine-stains-and-associated-syndromes\" class=\"medical medical_review\">Capillary malformations (port wine stains) and associated syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infantile-hemangiomas-epidemiology-pathogenesis-clinical-features-and-complications\" class=\"medical medical_review\">Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infantile-hemangiomas-management\" class=\"medical medical_review\">Infantile hemangiomas: Management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pyogenic-granuloma-lobular-capillary-hemangioma\" class=\"medical medical_review\">Pyogenic granuloma (Lobular capillary hemangioma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rapidly-involuting-congenital-hemangioma-rich-and-noninvoluting-congenital-hemangioma-nich\" class=\"medical medical_review\">Rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=skin-nodules-in-newborns-and-infants\" class=\"medical medical_review\">Skin nodules in newborns and infants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tufted-angioma-kaposiform-hemangioendothelioma-and-the-kasabach-merritt-phenomenon\" class=\"medical medical_review\">Tufted angioma, kaposiform hemangioendothelioma, and the Kasabach-Merritt phenomenon</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=venous-malformations\" class=\"medical medical_review\">Venous malformations</a></li></ul></div></div>","javascript":null}